Where to Appeal a TTAB Decision? The Choice is Complicated
John Welch co-authored an article published by World Trademark Review titled "Where to Appeal a TTAB Decision? The Choice is Complicated." Read more (subscription required).
Articles
Does the Buck(eye) Stop Here? Sixth Circuit Reinstates Ohio State Trademark Claims
An article written by John Strand and Kira-Khanh McCarthy, titled "Does the Buck(eye) Stop Here? Sixth Circuit Reinstates Ohio State Trademark Claims," featured in World Trademark Review. Read more (s...
The One-Year Time Bar Strikes Again
The time bar in Section 315(b) says that IPR may not be instituted if the petition was filed more than one year after the petitioner was “served with a complaint alleging infringement of the patent.” ...
The Federal Circuit Adds Color to Formulation Claims in Olaplex v. L’Oréal
(as published in the May 2021 issue of the American Chemical Society's Northeast Section publication of The Nucleus)
A Precautionary Tale: District Courts Take Varying Measures As In-Person Trials Appear on the Horizon
Roughly a year after lockdowns occurred nationwide, its impact on the country’s federal court system is still being felt. While the strain of the pandemic and its attendant restrictions are universall...
Boston Patent Law Association Response to a USPTO Notice of Proposed Rulemaking on Bayh-Dole Regulations
Jonathan Roses was the lead author on behalf of the Boston Patent Law Association’s (BPLA’s) Patent Office Practice and Licensing Committees of an April 2021 Response to a Notice of Proposed Rulemakin...
Finding the ‘Sweet Spot’ of Enablement in Amgen v. Sanofi: The Federal Circuit Provides Guidance on Enabling Antibody Claims
On February 11, 2021 the Federal Circuit upheld a United States District Court for the District of Delaware decision finding that Amgen’s function-only anti-PCSK9 monoclonal antibody claims were noten...
2020 Year in Review: Patent Decisions Impacting the Life Sciences
Authors: Jason Balich, K. Blake Chancellor, Sam Estabrooks, Eric Greenwald, Chelsea Loughran, Gabe McCool, Marie McKiernan, Kevin Mosier, Jonathan Roses, Claire Schuster, Charlie Steenburg, Patrick Wa...
Discretionary Denial at the PTAB Based on Parallel Litigation
Discretionary denial has been a hot topic at the PTAB. On Wednesday, February 24th, Wolf Greenfield hosted a webinar to discuss discretionary denial at the PTAB, and in particular, discretionary denia...
United States Annual Review: The Seventy-Third Year of Administration of the Lanham Act of 1946
John Welch co-authored the January-February 2021 edition of The Trademark Reporter, The Law Journal of The International Trademark Association (INTA). Titled “United States Annual Review: The Seventy-...
Boston Patent Law Association Response to USPTO Request for Comments on the National Strategy for Expanding American Innovation
Jonathan Roses was the lead author on behalf of the Boston Patent Law Association's (BPLA’s) Patent Office Practice and ad hoc Diversity & Inclusion Committees of a February 2021 Response to USPTO...
Expert Declarations in Inter Partes Review Proceedings Must Do More Than Create Noise: PTAB Silences Challenge to Patented Method for Cleaning “Noisy” Genetic Data
Overview On December 11, 2020, the PTAB issued a Final Written Decision in Illumina, Inc. v. Natera, Inc., IPR2019-01201, upholding the validity of Natera Inc.’s patent for determining genetic data fr...